General February 2020
2019 marked significant growth for CBE, as partners expanded their training and projects into Asia and worked with global companies on potential investments and ...
General Consulting February 2020
Perth-based PureIV, a CBE client, has obtained a TGA GMP license for sterile injectable compounding, in a significant breakthrough, mitigating serious potential risks to ...
General November 2019
October was another productive month at CBE, with ongoing reviews, audits and risk assessments. CBE director Alison Mew attended AusBiotech conference that featured several ...
Consulting October 2019
An innovative diagnostic tool to detect the early stages of tooth decay is moving towards global registration, with clinical trials set to commence in ...
